Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Andrew Patient Insider Profile
4 Followers
Andrew Patient, Senior Officer at IntelliPharmaCeutics International, holds 480.00K shares in Mimi's Rock (Ticker: MIMNF), holds 100.00K shares in IntelliPharmaCeutics International (Ticker: IPCIQ), holds 150.00K shares in Merus Labs International (Ticker: MSLI). Most recently, Andrew Patient Bought ― shares of Mimi's Rock on Sep 27, 2022 for an estimated value of 1.70K.
Andrew Patient IntelliPharmaCeutics International (IPCIQ)Senior Officer
IntelliPharmaCeutics International (IPCIQ)
Senior Officer
Ranked #177 out of 100,270 Corporate Insiders
Profitable Transactions
6 out of 25 Profitable Transactions
Average Return
+86.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Andrew Patient's holdings
Insider Roles
Senior Officer
Roles that Andrew Patient holds in companies
Most Profitable Insider Trade
Stock:
Mimi's Rock
(MIMNF)
(MIMNF)
Rating:Informative Buy
Date:Dec 24, 2019 - Dec 24, 2020
Return:+800.00%
The most profitable trade made by Andrew Patient
Andrew Patient's Trading History
IntelliPharmaCeutics International
May 15, 2018
Senior Officer
Informative Buy
11.71K
$15.00K
Merus Labs International
Mar 16, 2016
―
Informative Buy
19.00K
$900.00
Mimi's Rock
Sep 27, 2022
―
Informative Buy
1.70K
$71.52K
List of latest transactions for each holding click on a transaction to see Andrew Patient's performance on stock
You May Also Like
Andrew Patient insider profile FAQ
What is the percentage of profitable transactions made by Andrew Patient?
The percentage of profitable transactions made by Andrew Patient is 24%.
What is the average return per transaction made by Andrew Patient?
The average return per transaction made by Andrew Patient is 86.00%.
What stocks does Andrew Patient hold?
Andrew Patient holds: IPCIQ, MSLI, MIMNF stocks.
What was Andrew Patient’s latest transaction?
Andrew Patient latest transaction was an Informative Buy of $1.70K.
What was Andrew Patient's most profitable transaction?
Andrew Patient’s most profitable transaction was an Informative Buy of MIMNF stock on December 24, 2019. The return on the trade was 800.00%.
What is Andrew Patient's role in IntelliPharmaCeutics International?
Andrew Patient's role in IntelliPharmaCeutics International is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.